tiprankstipranks
Advertisement
Advertisement
Ondine to Spotlight Long-Term Infection Control Gains from Steriwave at Global Congress
PremiumCompany AnnouncementsOndine to Spotlight Long-Term Infection Control Gains from Steriwave at Global Congress
18d ago
Ondine’s Steriwave cuts ICU pneumonia in pilot study, signalling potential shift in infection control
Premium
Company Announcements
Ondine’s Steriwave cuts ICU pneumonia in pilot study, signalling potential shift in infection control
26d ago
Ondine Biomedical readies for next growth phase with Phase 3 completion and 29% revenue rise
Premium
Company Announcements
Ondine Biomedical readies for next growth phase with Phase 3 completion and 29% revenue rise
27d ago
Ondine’s Steriwave Shortlisted for 2025 Bionow Product of the Year
PremiumCompany AnnouncementsOndine’s Steriwave Shortlisted for 2025 Bionow Product of the Year
3M ago
Ondine’s Steriwave Chosen for Infection Control at New CAD$1.4bn Cowichan Hospital
Premium
Company Announcements
Ondine’s Steriwave Chosen for Infection Control at New CAD$1.4bn Cowichan Hospital
3M ago
Ondine’s Steriwave Enters Spanish ENT Surgery as Non‑Antibiotic Infection Control Tool
Premium
Company Announcements
Ondine’s Steriwave Enters Spanish ENT Surgery as Non‑Antibiotic Infection Control Tool
4M ago
Ondine Biomedical’s Innovative Approach to Prevent Surgical Infections: A Clinical Study Update
PremiumCompany AnnouncementsOndine Biomedical’s Innovative Approach to Prevent Surgical Infections: A Clinical Study Update
6M ago
Ondine Biomedical’s Innovative Approach to Reducing Surgical Infections: A Study Update
Premium
Company Announcements
Ondine Biomedical’s Innovative Approach to Reducing Surgical Infections: A Study Update
6M ago
Ondine Biomedical’s Steriwave Shows Promising Results in ICU Pathogen Reduction
Premium
Company Announcements
Ondine Biomedical’s Steriwave Shows Promising Results in ICU Pathogen Reduction
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100